Herpes simplex virus type 2 glycoprotein biogenesis: effect of monensin on glycoprotein maturation, intracellular transport and virus infectivity

J Gen Virol. 1987 Jul:68 ( Pt 7):1939-49. doi: 10.1099/0022-1317-68-7-1939.

Abstract

The ionophore monensin inhibited the formation of herpes simplex virus type 2 (HSV-2) particles by about 30% but the yields of infectious particles were reduced to 5% and 1% for cell-associated and extracellular virus, respectively. The presence of monensin did not affect the processing of the two viral glycoproteins gB-2 and gG-2. However, two other glycoproteins, gC-2 and gD-2, were not processed to their fully mature forms in the monensin-treated cells and only the faster moving pgC-2 and pgD-2 were detected. The cell-associated virus particles contained the glycoproteins gB-2, gC-2, gD-2 and gG-2, whereas the extracellular virus particles contained only gG-2 glycoprotein. These results suggest that HSV-2 particles containing all the viral glycoproteins are transported via the Golgi apparatus to the cell surface but that virus particles containing only gG-2 may follow a different pathway for transport and release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport / drug effects
  • Cricetinae
  • Fibroblasts / metabolism
  • Glycoproteins / biosynthesis*
  • Glycoproteins / physiology
  • Golgi Apparatus / physiology
  • Kidney
  • Mesocricetus
  • Monensin / pharmacology*
  • Oligosaccharides / metabolism
  • Protein Processing, Post-Translational / drug effects*
  • Simplexvirus / metabolism*
  • Simplexvirus / pathogenicity
  • Vero Cells
  • Viral Envelope Proteins / biosynthesis*
  • Viral Envelope Proteins / physiology
  • Virion / analysis
  • Virus Replication / drug effects

Substances

  • Glycoproteins
  • Oligosaccharides
  • Viral Envelope Proteins
  • Monensin